Source link : https://www.newshealth.biz/health-news/fda-approves-vorasidenib-for-certain-gliomas/
The US Food and Drug Administration (FDA) has approved vorasidenib (Voranigo, Servier) for the treatment of certain isocitrate dehydrogenase (IDH)–mutant diffuse gliomas, marking the first approval of a targeted therapy for these types of brain tumors. Specifically, the oral targeted inhibitor of IDH1 and IDH2 was approved for use after surgery in adults and children […]
Author : News Health
Publish date : 2024-08-06 22:25:00
Copyright for syndicated content belongs to the linked Source.
Categories